SEC and FDA Sign Memorandum of Understanding to Strengthen Market Integrity

The Securities and Exchange Commission (SEC) and the Food and Drug Administration (FDA) have announced the execution of a Memorandum of Understanding (MOU) designed to bolster cooperation between the two regulatory agencies. The agreement is established to assist both the SEC and the FDA in carrying out their respective regulatory and enforcement missions. By formalizing coordination and information sharing, the agencies aim to maintain market integrity, address potential regulatory overlaps, and enhance investor protection across regulated markets.